Modeling Sustained Treatment Effects in Tumor Xenograft Experiments

By        

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 4, 2014-07 ,pp. : 755-767

Taylor & Francis Ltd

Access to resources Recommend Favorite

Assessment of Antitumor Activity for Tumor Xenograft Studies Using Exponential Growth Models

By Wu Jianrong  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 3, 2011-05 ,pp. : 472-483

Taylor & Francis Ltd

Access to resources Recommend Favorite

Are we ready to take full advantage of patient‐derived tumor xenograft models?

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 24-27

John Wiley & Sons Inc

Access to resources Recommend Favorite

An Update on the Xenograft and Mouse Models Suitable for Investigating New Therapeutic Compounds for the Treatment of B-Cell Malignancies

By  

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2023-2039

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical models for pediatric solid tumor drug discovery: current trends, challenges and the scopes for improvement

By Kumar Sushil   Mokhtari Reza Bayat   Yeger Herman   Baruchel Sylvain  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 11, 2012-11 ,pp. : 1093-1106

Informa Healthcare

Access to resources Recommend Favorite